全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Marina D. Kaymakcalan , Suzanne S. Mickey ...
来源:[J].European Journal of Cancer(IF 5.061), 2016, Vol.52, pp.155-162Elsevier
摘要:Abstract(#br)Background(#br)A growing body of evidence has demonstrated the anti-neoplastic activity of statins. The objective of this study was to investigate the effect of statin use on survival in patients with metastatic renal cell carcinoma (mRCC) treated in the modern ...
作者:Marina D. Kaymakcalan , Nicole R. LeBoeuf
来源:[J].Current Opinion in Urology(IF 2.195), 2016, Vol.26 (6), pp.548-555Wolters Kluwer
摘要:PURPOSE OF REVIEW: Immune checkpoint inhibitors such as those that target the programmed cell death (PD)-1 pathway harness the host immune system to elicit an antitumor response. Their remarkable clinical benefit has led to regulatory approvals in several malignancies includ...
作者:Marina D. Kaymakcalan , Ole-Petter R. Hamnvik ...
来源:[J].Clinical Cancer Research(IF 7.837), 2015, Vol.21 (11), pp.2471-2479Duke University Press
摘要:Purpose: The renin-angiotensin system may play a role in carcinogenesis. The purpose of this study was to evaluate the impact of angiotensin system inhibitors (ASI) on outcomes in metastatic renal cell carcinoma (mRCC) patients treated in the targeted therapy era.Experimenta...
作者:... Rana R. McKay , Marina D. Kaymakcalan , Toni K. Choueiri
来源:[J].Surgical Pathology Clinics, 2015, Vol.8 (4), pp.657-662Elsevier
摘要:Abstract(#br)Renal cell carcinoma (RCC) is a heterogeneous disease. A rigorous diagnostic assessment by a pathologist with close communication with the clinician provides more accurate prognostication and informed treatment decisions. In the localized setting, an accurate prognos...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×